EquityFolio

JNJ

NYSE HEALTHCARE

Johnson & Johnson

$265.58

-$0.77 (-0.29%)

Live quote

52w: $173.33 – $281.07

Loading chart…
P/E Ratio18.82
P/B Ratio6.18
EV/EBITDA12.97
Debt/Equity0.59
ROE32.87%
ROIC13.71%
Revenue Growth0.00%
Gross Margin72.78%
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Own JNJ? Track it here.

Create a free account to add JNJ to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account